MolecularMD

MolecularMD Corporation develops and commercializes specialty molecular diagnostic products for oncology applications. MolecularMD's tests are designed to enable appropriate selection, monitoring, and management of patients treated with molecularly targeted cancer therapies. MolecularMD's assays combine gold-standard and innovative technologies to deliver high sensitivity, standardized, and reliable results that support clinical development, regulatory approval, and the commercialization of novel anticancer drugs.